Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for Corcept Therapeutics (CORT) over the last 9 years, with Q3 2025 value amounting to $188000.0.

  • Corcept Therapeutics' Amortizatization of Intangibles rose 386.74% to $188000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $11.1 million, marking a year-over-year increase of 3519.69%. This contributed to the annual value of $10.9 million for FY2024, which is 1982.91% up from last year.
  • As of Q3 2025, Corcept Therapeutics' Amortizatization of Intangibles stood at $188000.0, which was up 386.74% from $183000.0 recorded in Q2 2025.
  • In the past 5 years, Corcept Therapeutics' Amortizatization of Intangibles ranged from a high of $10.6 million in Q4 2024 and a low of -$6.6 million during Q4 2021
  • In the last 5 years, Corcept Therapeutics' Amortizatization of Intangibles had a median value of $496000.0 in 2021 and averaged $932526.3.
  • As far as peak fluctuations go, Corcept Therapeutics' Amortizatization of Intangibles plummeted by 145743.8% in 2021, and later skyrocketed by 129468.09% in 2023.
  • Quarter analysis of 5 years shows Corcept Therapeutics' Amortizatization of Intangibles stood at -$6.6 million in 2021, then surged by 108.58% to $564000.0 in 2022, then surged by 1294.68% to $7.9 million in 2023, then soared by 34.45% to $10.6 million in 2024, then plummeted by 98.22% to $188000.0 in 2025.
  • Its last three reported values are $188000.0 in Q3 2025, $183000.0 for Q2 2025, and $177000.0 during Q1 2025.